File Download
 
Links for fulltext
(May Require Subscription)
  • Find via
 
Supplementary

Conference Paper: Maximal early HBV suppression is predictive of optimal virologic and clinical efficacy in nucleoside-treated hepatitis B patients: scientific observations from a large multinational trial (the GLOBE study)
  • Basic View
  • Metadata View
  • XML View
TitleMaximal early HBV suppression is predictive of optimal virologic and clinical efficacy in nucleoside-treated hepatitis B patients: scientific observations from a large multinational trial (the GLOBE study)
 
AuthorsLai, CL
Gane, E
Liaw, YF
Thongsawat, S
Wang, YM
Chen, Y
Heathcote, J
Rasenack, J
Bzowej, N
Naoumov, N
Chao, G
Fielman, B
Brown, N
and the GLOBE Study Group, .
 
Issue Date2005
 
PublisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www.hepatology.org/
 
CitationHepatology, v. 42 n. Suppl 1, p. 232A [How to Cite?]
 
ISSN0270-9139
2013 Impact Factor: 11.190
 
DC FieldValue
dc.contributor.authorLai, CL
 
dc.contributor.authorGane, E
 
dc.contributor.authorLiaw, YF
 
dc.contributor.authorThongsawat, S
 
dc.contributor.authorWang, YM
 
dc.contributor.authorChen, Y
 
dc.contributor.authorHeathcote, J
 
dc.contributor.authorRasenack, J
 
dc.contributor.authorBzowej, N
 
dc.contributor.authorNaoumov, N
 
dc.contributor.authorChao, G
 
dc.contributor.authorFielman, B
 
dc.contributor.authorBrown, N
 
dc.contributor.authorand the GLOBE Study Group, .
 
dc.date.accessioned2010-09-25T20:50:41Z
 
dc.date.available2010-09-25T20:50:41Z
 
dc.date.issued2005
 
dc.identifier.citationHepatology, v. 42 n. Suppl 1, p. 232A [How to Cite?]
 
dc.identifier.hkuros121903
 
dc.identifier.issn0270-9139
2013 Impact Factor: 11.190
 
dc.identifier.issueSuppl 1
 
dc.identifier.openurl
 
dc.identifier.spage232
 
dc.identifier.urihttp://hdl.handle.net/10722/102931
 
dc.identifier.volume, v. 42 n. Suppl 1
 
dc.languageeng
 
dc.publisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www.hepatology.org/
 
dc.relation.ispartofHepatology
 
dc.rightsHepatology. Copyright © John Wiley & Sons, Inc.
 
dc.titleMaximal early HBV suppression is predictive of optimal virologic and clinical efficacy in nucleoside-treated hepatitis B patients: scientific observations from a large multinational trial (the GLOBE study)
 
dc.typeConference_Paper
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Lai, CL</contributor.author>
<contributor.author>Gane, E</contributor.author>
<contributor.author>Liaw, YF</contributor.author>
<contributor.author>Thongsawat, S</contributor.author>
<contributor.author>Wang, YM</contributor.author>
<contributor.author>Chen, Y</contributor.author>
<contributor.author>Heathcote, J</contributor.author>
<contributor.author>Rasenack, J</contributor.author>
<contributor.author>Bzowej, N</contributor.author>
<contributor.author>Naoumov, N</contributor.author>
<contributor.author>Chao, G</contributor.author>
<contributor.author>Fielman, B</contributor.author>
<contributor.author>Brown, N</contributor.author>
<contributor.author>and the GLOBE Study Group, .</contributor.author>
<date.accessioned>2010-09-25T20:50:41Z</date.accessioned>
<date.available>2010-09-25T20:50:41Z</date.available>
<date.issued>2005</date.issued>
<identifier.citation>Hepatology, v. 42  n. Suppl 1, p. 232A</identifier.citation>
<identifier.issn>0270-9139</identifier.issn>
<identifier.uri>http://hdl.handle.net/10722/102931</identifier.uri>
<language>eng</language>
<publisher>John Wiley &amp; Sons, Inc. The Journal&apos;s web site is located at http://www.hepatology.org/</publisher>
<relation.ispartof>Hepatology</relation.ispartof>
<rights>Hepatology. Copyright &#169; John Wiley &amp; Sons, Inc.</rights>
<title>Maximal early HBV suppression is predictive of optimal virologic and clinical efficacy in nucleoside-treated hepatitis B patients: scientific observations from a large multinational trial (the GLOBE study)</title>
<type>Conference_Paper</type>
<identifier.openurl>http://library.hku.hk:4550/resserv?sid=HKU:IR&amp;issn=0270-9139&amp;volume=42 &amp;issue=Suppl 1&amp;spage=232A&amp;epage=&amp;date=2005&amp;atitle=Maximal+early+HBV+suppression+is+predictive+of+optimal+virologic+and+clinical+efficacy+in+nucleoside-treated+hepatitis+B+patients:+scientific+observations+from+a+large+multinational+trial+(the+GLOBE+study)</identifier.openurl>
<identifier.hkuros>121903</identifier.hkuros>
<identifier.volume>, v. 42  n. Suppl 1</identifier.volume>
<identifier.issue>Suppl 1</identifier.issue>
<identifier.spage>232</identifier.spage>
</item>